Another Pharmaceutical Firm Settles SEC Bribery Charges

Posted 8/7/20

Boston-based Alexion Pharmaceuticals agreed July 2, 2020, to pay the Securities and Exchange Commission (SEC) more than $21 million to settle charges that it violated the Foreign Corrupt Practices …

This item is available in full to subscribers.

Please log in to continue

Log in